首页 产品中心 抗体 生化试剂 研究领域
服务与支持 定制服务 技术支持 促销活动 关于我们
登 录 注 册

ANGPTL3 Rabbit mAb  (货号:AYM30596)

A
小A 扫码咨询
宿主: Rabbit克隆性: Monoclonal反应: Human,Mouse,RatWBIF/ICC
货号 AYM30596
靶点/基因 ANGPTL3
宿主 Rabbit
克隆性 Monoclonal
反应种属 Human, Mouse, Rat
应用 WB, IF/ICC

货号:AYM30596

规格价格
50ul ¥1150.00 加购物车
100ul ¥2100.00 加购物车
  • 产品信息

  • 应用指南

  • 相关产品

  • 抗原信息

  • 靶点信息

  • 资料与支持

  • 实验步骤

  • 常见问题

反应 Human,Mouse,Rat
宿主 Rabbit
克隆性 Monoclonal
同种型 IgG
应用 WBIF/ICC
推荐浓度 WB: 1:500 - 1:2000
IF/ICC: 1:50 - 1:200
理论分子量 54kDa
实测分子量 54kDa
形式 Liquid
保存条件 Store at -20℃. Avoid freeze / thaw cycles.
Buffer: PBS with 0.75% BSA,50% glycerol,pH7.3.
偶联物 Unconjugated
阳性对照 HepG2,A375,Mouse lung,Mouse liver,Rat lung,Rat liver
细胞定位 Secreted
纯化 Affinity purification

应用与推荐条件

快速判断怎么用

以下条件基于推荐浓度、验证图说明与通用实验要求整理,可作为预实验起点;不同样本和检测体系建议做梯度优化。

WB WB 推荐条件
推荐稀释 1:500 - 1:2000
建议样本/阳性对照 HepG2,A375,Mouse lung,Mouse liver,Rat lung,Rat liver
关键条件 建议使用新鲜裂解样本,按推荐稀释比例孵育一抗,并关注理论/实测分子量
预期结果 预期信号/条带约 54kDa
对照设置 建议设置阳性样本、阴性样本和二抗/同型对照
IF/ICC IF/ICC 推荐条件
推荐稀释 1:50 - 1:200
建议样本/阳性对照 HepG2,A375,Mouse lung,Mouse liver,Rat lung,Rat liver
关键条件 建议优化固定、通透和封闭条件,并设置二抗空白对照
预期结果 预期荧光定位:Secreted
对照设置 建议设置阳性样本、阴性样本和二抗/同型对照

相关产品

查找相关产品 >>

抗原信息

抗原信息 Recombinant fusion protein corresponding to Human ANGPTL3.
序列
查看序列
MFTIKLLLFIVPLVISSRIDQDNSSFDSLSPEPKSRFAMLDDVKILANGLLQLGHGLKDFVHKTKGQINDIFQKLNIFDQSFYDLSLQTSEIKEEEKELR

靶点信息

研究背景 This gene encodes a member of a family of secreted proteins that function in angiogenesis. The encoded protein, which is expressed predominantly in the liver, is further processed into an N-terminal coiled-coil domain-containing chain and a C-terminal fibrinogen chain. The N-terminal chain is important for lipid metabolism, while the C-terminal chain may be involved in angiogenesis. Mutations in this gene cause familial hypobetalipoproteinemia type 2. [provided by RefSeq, Aug 2015]
基因 ID 27329
基因名 ANGPTL3
Swiss Q9Y5C1
别名 ANGPTL3,ANGPTL3 Rabbit mAb,Angiopoietin-5,Angiopoietin-like protein 3,ANGPT5
组织表达 Expressed principally in liver. Weakly expressed in kidney. Binds to adipocytes. Increased expression and colocalization with activated ITGB3 in glomeruli of patients with nephrotic syndrome showing effaced podocyte foot processes (at protein level).
功能 Acts in part as a hepatokine that is involved in regulation of lipid and glucose metabolism (PubMed:11788823, PubMed:12909640, PubMed:23661675, PubMed:25495645). Proposed to play a role in the trafficking of energy substrates to either storage or oxidative tissues in response to food intake (By similarity). Has a stimulatory effect on plasma triglycerides (TG), which is achieved by suppressing plasma TG clearance via inhibition of LPL activity. The inhibition of LPL activity appears to be an indirect mechanism involving recruitment of proprotein convertases PCSK6 and FURIN to LPL leading to cleavage and dissociation of LPL from the cell surface; the function does not require ANGPTL3 proteolytic cleavage but seems to be mediated by the N-terminal domain, and is not inhibited by GPIHBP1 (PubMed:12097324, PubMed:19318355, PubMed:20581395). Can inhibit endothelial lipase, causing increased plasma levels of high density lipoprotein (HDL) cholesterol and phospholipids (PubMed:17110602, PubMed:19028676). Can bind to adipocytes to activate lipolysis, releasing free fatty acids and glycerol (PubMed:12565906). Suppresses LPL specifically in oxidative tissues which is required to route very low density lipoprotein (VLDL)-TG to white adipose tissue (WAT) for storage in response to food; the function may involve cooperation with circulating, liver-derived ANGPTL8 and ANGPTL4 expression in WAT (By similarity). Contributes to lower plasma levels of low density lipoprotein (LDL)-cholesterol by a mechanism that is independent of the canonical pathway implicating APOE and LDLR. May stimulate hypothalamic LPL activity (By similarity).
研究领域

资料与技术支持

验证数据

1 张验证图

页面顶部轮播可查看应用验证图,覆盖 WB / IF/ICC。

文献引用

暂无公开文献关联,欢迎联系技术支持获取更多应用案例。

咨询案例
客户评价

暂无客户评价,使用后可提交评价与实验图片。

提交反馈
技术支持

可协助确认应用、样本、稀释比例、阳性/阴性对照和实验条件。

进入支持中心
需要确认应用条件?

请提供货号 AYM30596、实验应用、样本类型和检测体系,技术支持可协助确认稀释比例、阳性/阴性对照和 COA/批次资料。

常见问题

当前页面标注应用包括 WB, IF/ICC,建议结合页面验证图和推荐稀释比例进行预实验优化。
可通过页面询价/留言入口提交货号和批号,技术支持会协助提供对应批次资料。
页面推荐条件可作为起始浓度,不同样本、固定方式和检测体系可能需要梯度优化。

实验步骤

实验步骤
AYM30596